Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

eMI Aesthetics vs Lavender Sky Health

eMI Aesthetics
Graded #110

Higher grade

vs+1.6999999999999886
Lavender Sky Health
Graded #152

Lower grade

The verdict

eMI Aesthetics takes it — 70.1/100 to 68.4/100, but only just.

eMI Aesthetics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. eMI Aesthetics is a US direct-to-consumer telehealth brand offering doctor-guided GLP-1 weight loss programs to eligible patients in all 50 states. Lavender Sky Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLavender Sky Health +3
72
75
Dose & formulationeMI Aesthetics +20
84
64
Clinical oversightLavender Sky Health +4
70
74
Labs & monitoringLavender Sky Health +2
51
53
FulfillmentLavender Sky Health +4
77
81
Contract termsEven
55
55
eMI Aesthetics · left barLavender Sky Health · right bar

The numbers

MetriceMI AestheticsLavender Sky Health
WeighScore70.1/10068.4/100
GradeCC
Scorecard rank#110#152
Semaglutide$179/mo (all doses, compounded)$139/mo (starting dose, month to month, Southend Pharmacy, compounded)
TirzepatideNot disclosed$149/mo (starting dose, month to month, ReviveRx, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
eMI Aesthetics

Graded #110 · C

Strengths

  • Available to eligible patients in all 50 states
  • Offers both semaglutide and tirzepatide, plus an oral semaglutide option
  • Intake and provider visits run through OpenLoop Health, an established telehealth network

Where it loses points

  • Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
  • No fill pharmacy or named medical director is publicly listed
  • Support appears limited to email, with no phone number or hours published
Lavender Sky Health

Graded #152 · C

Strengths

  • The treatment-plan pricing page publishes every pharmacy's full ladder rather than one headline figure, so the cheaper prepaid tiers are visible alongside the monthly ones
  • A genuine month-to-month starter plan exists with no prepay, and the cheapest of them is what is filed above — Southend for semaglutide, ReviveRx for tirzepatide
  • Compounded plans include the price of the medication, and shipping and supplies are stated as included
  • Both semaglutide and tirzepatide are offered, across roughly ten named compounding pharmacies

Where it loses points

  • This is a marketplace, not one price: every figure belongs to a named pharmacy on a named plan, and the pharmacy and plan have to travel with the number for it to mean anything
  • Most of the ladder is prepaid — Tier plans need 8-10 weeks up front and Extended plans 3-4 months — and only a handful of the pharmacies publish a month-to-month starter plan at all
  • Brand-name plans add a separate $25 monthly treatment-plan fee and explicitly do not include the price of the medication; only the compounded plans include it
  • No price appears on the homepage, and the pricing page is the only place the ladders are published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard